What they were paid
Fulcrum Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $81,500 | — | $219,406 | — | $300,906 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Fulcrum Therapeutics, Inc. DEF 14A filed April 30, 2026, accession 0001193125-26-197196, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Fulcrum Therapeutics pays directors a $40,000 cash retainer.
Committees
FY2025 · as the proxy prints themAudit · Nominating/Governance
The rest of the Fulcrum Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Alan Ezekowitz | Independent Director | $273,047 |
| Alex C. Sapir | Director | $0 |
| Colin Hill | Independent Director | $264,406 |
| James Geraghty | Independent Director | $274,906 |
| Josh Lehrer | Director | — |
| Katina Dorton | Independent Director | $279,406 |
| Rachel King | Independent Director | $265,765 |
| Robert J. Gould | Director | $269,406 |
| Sonja L. Banks | Independent Director | $263,406 |
The full Fulcrum Therapeutics compensation record
free company briefThis page is one director within Fulcrum Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat